PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26628388-5	2016	In another set of experiments, WT mice were treated intraperitoneally either with vehicle or U18666A (seladin-1/DHCR24 inhibitor, 10 mg/kg) 30 minutes after middle cerebral artery occlusion.	3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one	93-100	24-dehydrocholesterol reductase	Mus musculus	102-111	
26628388-9	2016	Treatment of WT mice with the seladin-1/DHCR24 inhibitor U18666A also increased ischemic lesion.	3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one	57-64	24-dehydrocholesterol reductase	Mus musculus	30-39	
26628388-9	2016	Treatment of WT mice with the seladin-1/DHCR24 inhibitor U18666A also increased ischemic lesion.	3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one	57-64	24-dehydrocholesterol reductase	Mus musculus	40-46	
21845517-9	2012	Treatment of bones from wild-type mice with U18666A, a chemical inhibitor of DHCR24, resulted in short broad bones with a disrupted proliferating zone.	3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one	44-51	24-dehydrocholesterol reductase	Mus musculus	77-83